Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
That is all the official record says: ViewRay, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
In its own words
How the company describes itself to search engines on its website, word for word.
“MRIdian allows oncologists to visualize, adapt, and target using anatomical detail that is simply unavailable with conventional IGRT technologies.”
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 115 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by ViewRay, Inc.
Name
Role
Named in
Ajay A. Bansal
Executive officer
Feb 2017
Chris A. Raanes
Executive officer
Feb 2017
Douglas H. Keare
Executive officer
Feb 2017
James F. Dempsey
Executive officer
Feb 2017
Michael S. Cogswell
Executive officer
Feb 2017
D. David A. Chandler
Executive officer
Aug 2015
Michael F. Brandt
Executive officer
Aug 2015
Aditya S. Puri
Director
Feb 2017
Brian K. Roberts
Director
Feb 2017
Caley H. Castelein
Director
Feb 2017
Chris A. Raanes
Director
Feb 2017
David S. Bonita
Director
Feb 2017
Henry A. McKinnell, Jr.
Director
Feb 2017
James F. Dempsey
Director
Feb 2017
Joshua S. Bilenker
Director
Feb 2017
Mark S. Gold
Director
Feb 2017
Theodore T. Wang
Director
Feb 2017
Caley F. Castelein
Director
Aug 2015
About
Medical technology company based in Cleveland, Ohio.